TL;DR
- Cellular Intelligence aims to harness AI for accelerated medicine development
- Turing Award-winning researcher Yann LeCun joins the scientific advisory board
Summary
A recent analysis reveals that Cellular Intelligence is pioneering a groundbreaking approach to medicine development by leveraging AI to predict and control cellular behavior. This innovative strategy has the potential to significantly expedite the creation of new medicines, making them more accessible and affordable. The company's recent announcement of esteemed advisors, including Turing Award-winning AI researcher Yann LeCun, underscores the significance of this endeavor.
Content
A recent analysis reveals that Cellular Intelligence is pioneering a groundbreaking approach to medicine development by leveraging AI to predict and control cellular behavior. This innovative strategy has the potential to significantly expedite the creation of new medicines, making them more accessible and affordable. The company's recent announcement of esteemed advisors, including Turing Award-winning AI researcher Yann LeCun, underscores the significance of this endeavor. According to the original piece, Cellular Intelligence's AI model aims to replicate the predictability of text or image AI models, but for living cells. This ambitious goal is being pursued with the help of Moderna co-founder Robert 'Bob' Langer and chief executive of the Novo Nordisk Foundation, Jens Nielsen, who have joined the company's scientific advisory board. The reporting details the company's progress toward this goal, highlighting the potential for accelerated medicine development and the importance of strategic partnerships in achieving this vision.
ICYMI
- Cellular Intelligence's AI model seeks to predict and control cellular behavior
- Turing Award-winning researcher Yann LeCun joins the company's scientific advisory board
Original Post is from: Fortune
Read it here
See this article here: